TABLE 3

Changes in Main Outcome Measures Over Time According to Treatment Group

Treatment GroupChronic Disease Management (TRAQ)Health-Related Self-efficacy (PAM)Patient-Initiated Communications (Number of Contacts per Individual per Period)
Time and ScoresPTime and ScoresPTime and NumberP
MD2Me Baseline: 3.4 (0.9).02Baseline: 72 (17).028 months before study participation: 0 (0)<.0001
2 months: 3.5 (0.7)2 months: 79 (16)8-month study period: 2 (2)
8 months: 4.0 (0.8)8 months: 81 (17)
ControlBaseline: 3.6 (0.7)Baseline: 69 (17)8 months before study participation: 0 (0)
2 months: 3.8 (0.9)2 months: 69 (16)8-month study period: 0 (0)
8 months: 3.8 (0.8)8 months: 71 (14)
  • Data are presented as means (SD). Comparative analyses between treatment and control groups for each outcome measure used repeated measures models that included treatment group (intent-to-treat), age, disease, and baseline literacy scores. P values presented are from model comparisons of treatment group × time, controlling for the factors listed above. PAM, Patient Activation Measure; TRAQ, Transition Readiness Assessment Questionnaire.